|
Ocean Biomedical Inc (NASDAQ: OCEA) |
|
Ocean Biomedical Inc
OCEA's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Ocean Biomedical Inc 's sales fell
in the first quarter of 2025 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 4.44 %
Ocean Biomedical Inc faced net loss in contrast to the net income a year ago in first quarter of 2025
• More on OCEA's Growth
|
|
Ocean Biomedical Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Ocean Biomedical Inc PEG ratio is at -0
Company is currently trading with Price to Cash flow multiple of 2.5 in trailing twelve-month period. |
Company |
0.01 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.46.
• More on OCEA's Valuation
|
|
|
|
|
Ocean Biomedical Inc current PE on trailing twelve month basis is above Major Pharmaceutical Preparations industry average.
Ocean Biomedical Inc PEG ratio is at -0
Company is currently trading with Price to Cash flow multiple of 2.5 in trailing twelve-month period. |
Company |
0.01 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.46.
• More on OCEA's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com